Assignee
ADVAXIS INC
US13 patents
Top patents by PatentIndex Score
US10064898B2Sep 4, 2018
Listeria-based adjuvants
ADVAXIS INC7 citations82
US9650639B2May 16, 2017
Dual delivery system for heterologous antigens
ADVAXIS INC11 citations82
US9644212B2May 9, 2017
Dual delivery system for heterologous antigens
ADVAXIS INC11 citations82
US10900044B2Jan 26, 2021
Listeria-based compositions comprising a peptide minigene expression system and methods of use thereof
ADVAXIS INC6 citations80
US9907849B2Mar 6, 2018
Combination of a PD-1 antagonist and a listeria-based vaccine for treating prostate cancer
ADVAXIS INC10 citations78
US10143734B2Dec 4, 2018
Biomarker directed multi-target immunotherapy
ADVAXIS INC6 citations73
US11446369B2Sep 20, 2022
Compositions and methods comprising KLK3 or FOLH1 antigen
ADVAXIS INC3 citations72
US10258679B2Apr 16, 2019
Recombinant Listeria vaccine strains and methods of producing the same
ADVAXIS INC6 citations72
US10058599B2Aug 28, 2018
Suppressor cell function inhibition following Listeria vaccine treatment
ADVAXIS INC6 citations71
US11702664B2Jul 18, 2023
Listeria-based compositions comprising a peptide minigene expression system and methods of use thereof
ADVAXIS INC2 citations69
US11179339B2Nov 23, 2021
Compositions and methods for lyophilization of bacteria or listeria strains
ADVAXIS INC4 citations64
US12239738B2Mar 4, 2025
Compositions and methods for lyophilization of bacteria or listeria strains
ADVAXIS INC0 citations54
US11897927B2Feb 13, 2024
Immunogenic compositions targeting recurrent cancer mutations and methods of use thereof
ADVAXIS INC1 citations51